The Latest: Pfizer-BioNTech data shows vaccine easier to use
|
February 25, 2021 5:15 AM
NEW YORK — New data indicate the COVID-19 vaccine developed by Pfizer and German partner BioNTech could be stored for two weeks without the ultracold storage currently required, potentially making its use a bit easier.
Become a Subscriber!
You have read all of your free articles this month. Select a plan below to start your subscription today.
Already a subscriber? Login
